Bruker, Serva in Proteomic Reagent Co-Marketing Pact

Bruker Daltonics will co-market and sell a labeling reagent for quantitative proteomics for Serva Electrophoresis of Heidelberg, Germany, the companies said this week.

The technology, called Isotope Coded Protein Label, or ICPL, was developed by researchers at the Max-Planck-Institute of Biochemistry in Martinsried, Germany, and is exclusively licensed to Serva. Under the new agreement, Bruker will provide ICPL kits worldwide.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Associated Press reports that gene-edited food may soon be for sale.

The United Nations is to consider a ban on field testing gene drives at a meeting being held next week, Technology Review reports.

The US Department of Health and Human Services is beginning a series of meetings on human fetal tissue research, Stat News reports.

In Cell this week: epigenetic change linked to glioblastomas, rare and low-frequency variants contributing to multiple sclerosis risk, and more.